新型コロナウイルス感染症(COVID-19)関連情報

お知らせ

感染研市民セミナー 「最近のヒト・動物インフルエンザの流行状況」

  感染研市民セミナー(第49回) 「くらしに役立つ病気の知識」  最近のヒト・動物インフルエンザの流行状況   国立感染症研究所(村山庁舎)では、毎日を健康に明るく過ごすための情報を、分かりやすく提供する市民公開セミナー「くらしに役立つ病気の知識」をシリーズ...

続きを読む

IASR最新号 特集記事

IASR 45(4), 風疹・先天性風疹症候群 2024年2月現在

  風疹・先天性風疹症候群 2024年2月現在 (IASR Vol. 45 p51-52: 2024年4月号)   風疹は風疹ウイルスによる急性感染症であり, 発熱, 発疹, リンパ節腫脹を主徴とする。風疹に対する免疫が不十分な妊婦が風疹ウイル...

続きを読む

Jpn. J. Infect. Dis., 65 (2), 138-145, 2012

To see a printable version of the article in the Adobe file format, click this [PDF] link.

Haiyang Zhao, Keiji Nakamura, Tomoko Kohda, Masafumi Mukamoto, and Shunji Kozaki*

Department of Veterinary Science, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, Osaka 598-8531, Japan

(Received October 27, 2011. Accepted December 19, 2011)


*Corresponding author: Mailing address: Department of Veterinary Science, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, 1-58 Rinku Ourai Kita, Izumisano-shi, Osaka 598-8531, Japan. Tel: +81-72-463-5690, Fax: +81-72-463-5691, E-mail: このメールアドレスはスパムボットから保護されています。閲覧するにはJavaScriptを有効にする必要があります。


SUMMARY: Clostridium botulinum produces large complex toxins, which include botulinum neurotoxin (BoNT) and auxiliary non-toxic proteins. We prepared monoclonal antibodies (mAbs) from mice that were immunized several times with BoNT/A after basal immunization with toxoid. We then examined the reactivities of these mAbs to BoNT and toxoid and showed that some mAbs reacted to only BoNT. This result indicates that the antigenicity of BoNT/A partially disappeared with formalin treatment. Some mAbs that specifically recognized either BoNT/A1 or BoNT/A2 were considered useful as detection antibodies specific for the BoNT/A subtype. Results of a neutralizing test with mAbs against either BoNT/A1 or BoNT/A2 showed that neutralizing antibody recognition sites were present in the light chain, heavy chain (N-terminal half), and heavy chain (C-terminal half) domains. Investigation of the different binding capabilities of the mAbs to BoNT and the complex toxin by immunoprecipitation suggested that the light chain of BoNT is exposed at the molecular surface of the complex toxin since there was no difference in the binding of light chain-specific mAb to BoNT and the complex toxin. The heavy chain is related to BoNT binding to non-toxic components, because the reactivity of the heavy chain to some mAbs was influenced by non-toxic components.

Copyright 1998 National Institute of Infectious Diseases, Japan